American Journal of Epidemiology Advance Access published online on January 4, 2007
American Journal of Epidemiology, doi:10.1093/aje/kwk054
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL CONTRIBUTIONS |
Alcohol Consumption and Breast Cancer Risk in the Women's Health Study
1 Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
2 Department of Epidemiology, Harvard School of Public Health, Boston, MA
3 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
4 Department of Nutrition, Harvard School of Public Health, Boston, MA
5 Department of Ambulatory Care and Prevention, Harvard Medical School, Boston, MA
Correspondence to Dr. Shumin M. Zhang, Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215 (e-mail: shumin.zhang{at}channing.harvard.edu).
The authors assessed the association between moderate alcohol consumption and breast cancer risk in the Women's Health Study (United States, 1992–2004). During an average of 10 years of follow-up, 1,484 cases of total breast cancer (1,190 invasive and 294 in situ) were documented among 38,454 women who, at baseline, were free of cancer and cardiovascular disease and provided detailed dietary information, including alcohol consumption, for the preceding 12 months. Higher alcohol consumption was associated with a modest increase in breast cancer risk; the multivariable relative risks for 
30 g/day of alcohol vs. none were 1.32 (95% confidence interval (CI): 0.96, 1.82) for total breast cancer and 1.43 (95% CI: 1.02, 2.02) for invasive breast cancer. An increased risk was limited to estrogen receptor (ER)– and progesterone receptor (PR)–positive tumors; the multivariable relative risks for an increment of 10 g/day of alcohol were 1.11 (95% CI: 1.03, 1.20) for ER+PR+ tumors (804 cases), 1.00 (95% CI: 0.81, 1.24) for ER+PR– tumors (125 cases), and 0.99 (95% CI: 0.82, 1.20) for ER–PR– tumors (167 cases). The association also seemed strongest among those taking postmenopausal hormones currently, but the test for interaction was not significant. The findings from this prospective study suggest that moderate alcohol consumption increases breast cancer risk.
alcohol drinking; breast neoplasms; prospective studies; receptors, estrogen; receptors, progesterone
Abbreviations: CI, confidence interval; ER, estrogen receptor; PR, progesterone receptor
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Deandrea, R. Talamini, R. Foschi, M. Montella, L. Dal Maso, F. Falcini, C. La Vecchia, S. Franceschi, and E. Negri Alcohol and Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Case-Control Study Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2025 - 2028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Reding, J. R. Daling, D. R. Doody, C. A. O'Brien, P. L. Porter, and K. E. Malone Effect of Prediagnostic Alcohol Consumption on Survival after Breast Cancer in Young Women Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1988 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Grady, J. A. Cauley, M. J. Geiger, M. Kornitzer, L. Mosca, P. Collins, N. K. Wenger, J. Song, J. Mershon, E. Barrett-Connor, et al. Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary Risk J Natl Cancer Inst, June 18, 2008; 100(12): 854 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Zhang, J. Lin, N. R. Cook, I-M. Lee, J. E. Manson, J. E. Buring, and P. M. Ridker C-Reactive Protein and Risk of Breast Cancer J Natl Cancer Inst, June 6, 2007; 99(11): 890 - 894. [Abstract] [Full Text] [PDF]
|
|